Quick Takeaways: Why It Matters? The planned separation positions Noviwest and Panavora to pursue more focused strategies across specialty ingredients and animal nutrition, respectively. Panavora could strengthen its competitive position by integrating feed additives, pre...
Quick Takeaways: Why It Matters? Zoetis strengthens its companion animal dermatology portfolio with Convenia RTU, offering a more concentrated formulation of an established long-acting injectable antibiotic. Reduced administration burden could improve adherence and differentiat...
Cover Story Featured Article Research Findings Clinical Program Update Peer-Reviewed Comparison Product Expansion Brand & Market Entry Neion Bio Partners With Barnwell Bio to Strengthen Flock Health Monitoring Strategic Collaboration Neion Bio and Barnwell Bio have en...
Quick Takeaways: Why It Matters? PetVivo’s preliminary macaque studies add early evidence for Spryng’s potential in osteoarthritis management, combining mobility improvements with encouraging local tissue-response findings. The data could support further development of its inje...
Cover Story Featured Article Product Launch Distribution Expansion Regulatory Milestone Study Results Bora Biologics and Protect Animal Health Partner to Advance Veterinary Antibody Pipeline Strategic Collaboration Bora Biologics and Protect Animal Health have entered a long-term, multi-pr...
Quick Takeaways: Why It Matters? OST-HER2’s potential conditional licensure could give OSAH a first-mover advantage in HER2-targeted canine osteosarcoma, an area with limited treatment options. A 2027 launch could establish a differentiated oncology franchise, while validating ...
Quick Takeaways: Why It Matters? CannEpil’s MUMS designation could give Endovia and Lupvindol an early-mover advantage in veterinary oncology pain management, particularly if the conditional pathway enables faster commercialization. A potential 2027 launch may expand cannabinoi...
Quick Takeaways: Why It Matters? Bora Biologics’ first animal‑health collaboration with Protect Animal Health gives Protect a U.S./Taiwan CDMO partner (CHO‑K1 cell line, process development, scale‑up, manufacturing) to advance at least three antibody programs (two mAbs, o...
Quick Takeaways: Why It Matters? Novel’s partnership with Airvet—becoming Airvet’s first Canadian veterinary partner—extends virtual triage and prescription access to Ontario pet families, with Novel fulfilling and delivering approved medications next‑day, 7 days/week at no add...
Quick Takeaways: Why It Matters? Cronus Pharma’s launch of Florfinasone Otic (florfenicol + terbinafine + mometasone) adds an FDA‑approved, single‑use, triple‑action topical for canine otitis externa to a growing companion‑animal ear‑infection market. The fixed‑dose combination...
